Compared to Estimates, Dolby Laboratories (DLB) Q1 Earnings: A Look at Key Metrics

Zacks
31 Jan

Dolby Laboratories (DLB) reported $357 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 13.1%. EPS of $1.14 for the same period compares to $1.01 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $346.37 million, representing a surprise of +3.07%. The company delivered an EPS surprise of +6.54%, with the consensus EPS estimate being $1.07.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Dolby Laboratories performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Products and services: $26.52 million versus the three-analyst average estimate of $25.24 million. The reported number represents a year-over-year change of +21.6%.
  • Revenue- Licensing: $330.48 million versus $321.12 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +12.5% change.
  • Gross Margin- Licensing: $309.37 million versus $301.40 million estimated by three analysts on average.
  • Gross margin- Products and services: $6.86 million compared to the $3.83 million average estimate based on three analysts.
View all Key Company Metrics for Dolby Laboratories here>>>

Shares of Dolby Laboratories have returned +3.2% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Dolby Laboratories (DLB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10